Description

Indian Pharma 2030: Global Leadership with Foresight examines India’s pharmaceutical sector, tracing its evolution, growth in the last decade and future potential. It covers regulatory frameworks, global harmonisation efforts, and emerging trends like biosimilars, APIs and lifestyle disease treatments. The book outlines strategies for achieving pharmaceutical leadership by 2030, including increased generic medicine adoption, biosimilar market expansion and CDMO opportunities. Highlighting India’s vision, the book emphasises integration with international regulatory systems and innovation-driven R&D, presenting a roadmap for global leadership in pharmaceuticals.